Levin Capital Strategies’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Levin Capital Strategies’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-45,775	Closed	-$7.32K	–	319
2023 Q2	$7.32K	Hold	45,775	–	–	﹤0.01%	268
2023 Q1	$5.49K	Hold	45,775	–	–	﹤0.01%	240
2022 Q4	$10.3K	Sell	45,775 -31,250	-41%	-$12.9K	﹤0.01%	238
2022 Q3	$34K	Buy	77,025 +34,550	+81%	+$23.5K	﹤0.01%	224
2022 Q2	$21K	Sell	42,475 -20,025	-32%	-$12.6K	﹤0.01%	258
2022 Q1	$49K	Hold	62,500	–	–	﹤0.01%	300
2021 Q4	$100K	Hold	62,500	–	–	0.01%	305
2021 Q3	$433K	Buy	62,500 +25,800	+70%	+$139K	0.04%	186
2021 Q2	$176K	Sell	36,700 -38,300	-51%	-$142K	0.02%	305
2021 Q1	$212K	Sell	75,000 -287,000	-79%	-$578K	0.02%	240
2020 Q4	$424K	Buy	362,000 +10,000	+3%	+$9.04K	0.05%	172
2020 Q3	$295K	Buy	352,000 +12,500	+4%	+$11.9K	0.04%	197
2020 Q2	$350K	Buy	339,500 +10,000	+3%	+$11K	0.05%	121
2020 Q1	$306K	Sell	329,500 -350,000	-52%	-$279K	0.05%	106
2019 Q4	$264K	Buy	679,500 +28,533	+4%	+$8.96K	0.03%	166
2019 Q3	$208K	Buy	650,967 +26,900	+4%	+$9.16K	0.02%	173
2019 Q2	$262K	Buy	624,067 +398,805	+177%	+$160K	0.03%	159
2019 Q1	$87K	Buy	225,262 +18,262	+9%	+$6.43K	0.01%	188
2018 Q4	$66K	Buy	207,000 +6,084	+3%	+$2.04K	﹤0.01%	245
2018 Q3	$94K	Buy	200,916 +42,380	+27%	+$21K	﹤0.01%	261
2018 Q2	$54K	Buy	+158,536	New	+$78.1K	﹤0.01%	279

Other funds holding PAVMZ

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Levin Capital Strategies's PAVMZ Position: Q3 2023 in Review

Levin Capital Strategies sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q3 2023, closing a stake of 45,775 shares — an estimated $7.32K sold.

Levin Capital Strategies first reported a position in PAVMZ in Q2 2018 and held it in 21 quarters. The position peaked at $433K in Q3 2021. 4 funds tracked by Wall St. Rank hold PAVMZ as of Q3 2023.

Levin Capital Strategies reported no remaining PAVmed Inc. Series Z Warrant position as of Q3 2023 after selling out during the quarter.
Levin Capital Strategies sold 45,775 PAVmed Inc. Series Z Warrant shares in Q3 2023, an estimated $7.32K.
Levin Capital Strategies first reported a position in PAVmed Inc. Series Z Warrant in Q2 2018 and held it in 21 quarters.
Levin Capital Strategies's PAVmed Inc. Series Z Warrant position peaked at $433K in Q3 2021.
4 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q3 2023.

Based on Levin Capital Strategies's 13F filing for Q3 2023, filed 31 Oct 2023.